UniProt ID ▼ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A337S9Z4 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A337S9K0 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A337S859 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
A0A337S578 | L-selectin |
|
3 | 0 |
|
A0A337S4G8 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A337S2N6 | P2X purinoceptor |
|
1 | 0 |
|
A0A337S157 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A337S0Z7 | P2X purinoceptor |
|
1 | 0 |
|
A0A337RZF5 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A337RZA8 | Hyaluronidase |
|
1 | 0 |
|
A0A2I2V3Y5 | Angiotensin-converting enzyme |
|
6 | 0 |
|
A0A2I2V0R4 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A2I2V0N7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I2UXQ2 | P2X purinoceptor |
|
1 | 0 |
|
A0A2I2UU74 | Paraoxonase |
|
3 | 0 |
|
A0A2I2UTZ7 | Angiotensin-converting enzyme |
|
12 | 0 |
|
A0A2I2UK29 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A2I2UGF1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I2UFV4 | GDNF family receptor alpha-2 |
|
2 | 0 |
|
A0A2I2UDL8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I2UAM3 | Voltage-dependent L-type calcium channel subunit alpha |
|
2 | 0 |
|
A0A2I2U7C9 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I2U6Y1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I2U4K7 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I2U2W4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024